Home
Reels
Groups
Pages
See More
Groups Pages Events Blogs Funding
Sign In Sign Up
Night Mode
Targeted Therapy and the NSCLC Market: Matching Drugs to Mutations
Targeted therapies have transformed outcomes for subsets of NSCLC patients — and they are a major growth driver within the non-small cell lung cancer market. By matching drugs to specific genetic alterations, targeted therapy offers higher response rates and better tolerability than traditional chemotherapy for patients whose tumours carry actionable mutations. Key targets include EGFR,...
0 Comments ·0 Shares ·23 Views ·0 Reviews
Please log in to like, share and comment!